Selected research
Industry Growth & Trends
Global GFAP Antibody Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global GFAP Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for GFAP Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for GFAP Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for GFAP Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the GFAP Antibody market include Merck, Synaptic Systems, Sino Biological, Santa Cruz Biotechnology, Proteintech, ProSci, Miltenyi Biotec, Hytest and GeneTex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global GFAP Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The GFAP Antibody market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global GFAP Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to GFAP Antibody.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global GFAP Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
GFAP Antibody Market by Company
Merck
Synaptic Systems
Sino Biological
Santa Cruz Biotechnology
Proteintech
ProSci
Miltenyi Biotec
Hytest
GeneTex
FineTest
Enzo Life Sciences
EnCor Biotechnology
Aviva Systems Biology
Atlas Antibodies
GFAP Antibody Segment by Type
Polyclonal
Monoclonal
GFAP Antibody Segment by Application
Immunohistochemistry Paraffin
Immunohistochemistry Frozen
Immunofluorescence
Western Blot
Others
GFAP Antibody Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GFAP Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GFAP Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GFAP Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of GFAP Antibody companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Polyclonal
- Monoclonal
Applications
- Immunohistochemistry Paraffin
- Immunohistochemistry Frozen
- Immunofluorescence
- Western Blot
- Others
Companies covered
- Merck
- Synaptic Systems
- Sino Biological
- Santa Cruz Biotechnology
- Proteintech
- ProSci
- Miltenyi Biotec
- Hytest
- GeneTex
- FineTest
- Enzo Life Sciences
- EnCor Biotechnology
- Aviva Systems Biology
- Atlas Antibodies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global GFAP Antibody Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global GFAP Antibody Market Size by Region (2021-2032)
- 1.4.1 Global GFAP Antibody Market Size by Region (2021-2026)
- 1.4.2 Global GFAP Antibody Market Size by Region (2027-2032)
- 1.5 Key Regions GFAP Antibody Market Size (2021-2032)
- 1.5.1 North America GFAP Antibody Market Size Growth Rate (2021-2032)
- 1.5.2 Europe GFAP Antibody Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific GFAP Antibody Market Size Growth Rate (2021-2032)
- 1.5.4 South America GFAP Antibody Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa GFAP Antibody Market Size Growth Rate (2021-2032)
2 GFAP Antibody Market by Type
- 2.1 Type Introduction
- 2.1.1 Polyclonal
- 2.1.2 Monoclonal
- 2.2 Global GFAP Antibody Market Size by Type
- 2.2.1 Global GFAP Antibody Market Size Overview by Type (2021-2032)
- 2.2.2 Global GFAP Antibody Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global GFAP Antibody Market Size Forecasted by Type (2027-2032)
- 2.3 Global GFAP Antibody Market Size by Regions
- 2.3.1 North America GFAP Antibody Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe GFAP Antibody Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific GFAP Antibody Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America GFAP Antibody Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa GFAP Antibody Market Size Breakdown by Type (2021-2026)
3 GFAP Antibody Market by Application
- 3.1 Type Introduction
- 3.1.1 Immunohistochemistry Paraffin
- 3.1.2 Immunohistochemistry Frozen
- 3.1.3 Immunofluorescence
- 3.1.4 Western Blot
- 3.1.5 Others
- 3.2 Global GFAP Antibody Market Size by Application
- 3.2.1 Global GFAP Antibody Market Size Overview by Application (2021-2032)
- 3.2.2 Global GFAP Antibody Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global GFAP Antibody Market Size Forecasted by Application (2027-2032)
- 3.3 Global GFAP Antibody Market Size by Regions
- 3.3.1 North America GFAP Antibody Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe GFAP Antibody Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific GFAP Antibody Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America GFAP Antibody Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa GFAP Antibody Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 GFAP Antibody Industry Trends
- 4.2 GFAP Antibody Industry Drivers
- 4.3 GFAP Antibody Industry Opportunities and Challenges
- 4.4 GFAP Antibody Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by GFAP Antibody Revenue (2021-2026)
- 5.2 Global GFAP Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global GFAP Antibody Key Company Headquarters & Area Served
- 5.4 Global GFAP Antibody Company, Product Type & Application
- 5.5 Global GFAP Antibody Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global GFAP Antibody Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 GFAP Antibody Players Market Share by Revenue in 2025
- 5.6.3 2025 GFAP Antibody Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Merck
- 6.1.1 Merck Company Information
- 6.1.2 Merck Business Overview
- 6.1.3 Merck GFAP Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Merck GFAP Antibody Product Portfolio
- 6.1.5 Merck Recent Developments
- 6.2 Synaptic Systems
- 6.2.1 Synaptic Systems Company Information
- 6.2.2 Synaptic Systems Business Overview
- 6.2.3 Synaptic Systems GFAP Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Synaptic Systems GFAP Antibody Product Portfolio
- 6.2.5 Synaptic Systems Recent Developments
- 6.3 Sino Biological
- 6.3.1 Sino Biological Company Information
- 6.3.2 Sino Biological Business Overview
- 6.3.3 Sino Biological GFAP Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Sino Biological GFAP Antibody Product Portfolio
- 6.3.5 Sino Biological Recent Developments
- 6.4 Santa Cruz Biotechnology
- 6.4.1 Santa Cruz Biotechnology Company Information
- 6.4.2 Santa Cruz Biotechnology Business Overview
- 6.4.3 Santa Cruz Biotechnology GFAP Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Santa Cruz Biotechnology GFAP Antibody Product Portfolio
- 6.4.5 Santa Cruz Biotechnology Recent Developments
- 6.5 Proteintech
- 6.5.1 Proteintech Company Information
- 6.5.2 Proteintech Business Overview
- 6.5.3 Proteintech GFAP Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Proteintech GFAP Antibody Product Portfolio
- 6.5.5 Proteintech Recent Developments
- 6.6 ProSci
- 6.6.1 ProSci Company Information
- 6.6.2 ProSci Business Overview
- 6.6.3 ProSci GFAP Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 ProSci GFAP Antibody Product Portfolio
- 6.6.5 ProSci Recent Developments
- 6.7 Miltenyi Biotec
- 6.7.1 Miltenyi Biotec Company Information
- 6.7.2 Miltenyi Biotec Business Overview
- 6.7.3 Miltenyi Biotec GFAP Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Miltenyi Biotec GFAP Antibody Product Portfolio
- 6.7.5 Miltenyi Biotec Recent Developments
- 6.8 Hytest
- 6.8.1 Hytest Company Information
- 6.8.2 Hytest Business Overview
- 6.8.3 Hytest GFAP Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Hytest GFAP Antibody Product Portfolio
- 6.8.5 Hytest Recent Developments
- 6.9 GeneTex
- 6.9.1 GeneTex Company Information
- 6.9.2 GeneTex Business Overview
- 6.9.3 GeneTex GFAP Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 GeneTex GFAP Antibody Product Portfolio
- 6.9.5 GeneTex Recent Developments
- 6.10 FineTest
- 6.10.1 FineTest Company Information
- 6.10.2 FineTest Business Overview
- 6.10.3 FineTest GFAP Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 FineTest GFAP Antibody Product Portfolio
- 6.10.5 FineTest Recent Developments
- 6.11 Enzo Life Sciences
- 6.11.1 Enzo Life Sciences Company Information
- 6.11.2 Enzo Life Sciences Business Overview
- 6.11.3 Enzo Life Sciences GFAP Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Enzo Life Sciences GFAP Antibody Product Portfolio
- 6.11.5 Enzo Life Sciences Recent Developments
- 6.12 EnCor Biotechnology
- 6.12.1 EnCor Biotechnology Company Information
- 6.12.2 EnCor Biotechnology Business Overview
- 6.12.3 EnCor Biotechnology GFAP Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 EnCor Biotechnology GFAP Antibody Product Portfolio
- 6.12.5 EnCor Biotechnology Recent Developments
- 6.13 Aviva Systems Biology
- 6.13.1 Aviva Systems Biology Company Information
- 6.13.2 Aviva Systems Biology Business Overview
- 6.13.3 Aviva Systems Biology GFAP Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Aviva Systems Biology GFAP Antibody Product Portfolio
- 6.13.5 Aviva Systems Biology Recent Developments
- 6.14 Atlas Antibodies
- 6.14.1 Atlas Antibodies Company Information
- 6.14.2 Atlas Antibodies Business Overview
- 6.14.3 Atlas Antibodies GFAP Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Atlas Antibodies GFAP Antibody Product Portfolio
- 6.14.5 Atlas Antibodies Recent Developments
7 North America
- 7.1 North America GFAP Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America GFAP Antibody Market Size by Country (2021-2026)
- 7.3 North America GFAP Antibody Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe GFAP Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe GFAP Antibody Market Size by Country (2021-2026)
- 8.3 Europe GFAP Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific GFAP Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific GFAP Antibody Market Size by Country (2021-2026)
- 9.3 Asia-Pacific GFAP Antibody Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America GFAP Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America GFAP Antibody Market Size by Country (2021-2026)
- 10.3 South America GFAP Antibody Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa GFAP Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa GFAP Antibody Market Size by Country (2021-2026)
- 11.3 Middle East & Africa GFAP Antibody Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst